Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Selection criteria for early breast cancer patients in the DBCG proton trial - The randomised phase III trial strategy.
Stick LB, Lorenzen EL, Yates ES, Anandadas C, Andersen K, Aristei C, Byrne O, Hol S, Jensen I, Kirby AM, Kirova YM, Marrazzo L, Matías-Pérez A, Nielsen MMB, Nissen HD, Oliveros S, Verhoeven K, Vikström J, Offersen BV. Stick LB, et al. Among authors: yates es. Clin Transl Radiat Oncol. 2021 Feb 4;27:126-131. doi: 10.1016/j.ctro.2021.01.012. eCollection 2021 Mar. Clin Transl Radiat Oncol. 2021. PMID: 33659716 Free PMC article.
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Eldesoky AR, Yates ES, Nyeng TB, Thomsen MS, Nielsen HM, Poortmans P, Kirkove C, Krause M, Kamby C, Mjaaland I, Blix ES, Jensen I, Berg M, Lorenzen EL, Taheri-Kadkhoda Z, Offersen BV. Eldesoky AR, et al. Among authors: yates es. Radiother Oncol. 2016 Dec;121(3):424-430. doi: 10.1016/j.radonc.2016.09.005. Epub 2016 Sep 30. Radiother Oncol. 2016. PMID: 27697296
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.
Francolini G, Thomsen MS, Yates ES, Kirkove C, Jensen I, Blix ES, Kamby C, Nielsen MH, Krause M, Berg M, Mjaaland I, Schreiber A, Kasti UM, Boye K, Offersen BV. Francolini G, et al. Among authors: yates es. Radiother Oncol. 2017 May;123(2):282-287. doi: 10.1016/j.radonc.2017.03.011. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351523 Clinical Trial.
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study.
Eldesoky AR, Francolini G, Thomsen MS, Yates ES, Nyeng TB, Kirkove C, Kamby C, Blix ES, Nielsen MH, Taheri-Kadkhoda Z, Berg M, Offersen BV. Eldesoky AR, et al. Among authors: yates es. Clin Transl Radiat Oncol. 2017 Feb 6;2:36-40. doi: 10.1016/j.ctro.2017.01.004. eCollection 2017 Feb. Clin Transl Radiat Oncol. 2017. PMID: 29657998 Free PMC article.
Delineation of whole heart and substructures in thoracic radiation therapy: National guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups.
Milo MLH, Offersen BV, Bechmann T, Diederichsen ACP, Hansen CR, Holtved E, Josipovic M, Lörincz T, Maraldo MV, Nielsen MH, Nordsmark M, Nyström PW, Pøhl M, Rose HK, Schytte T, Yates ES, Lorenzen EL. Milo MLH, et al. Among authors: yates es. Radiother Oncol. 2020 Sep;150:121-127. doi: 10.1016/j.radonc.2020.06.015. Epub 2020 Jun 13. Radiother Oncol. 2020. PMID: 32544606
Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation.
Kaidar-Person O, Nissen HD, Yates ES, Andersen K, Boersma LJ, Boye K, Canter R, Costa E, Daniel S, Hol S, Jensen I, Lorenzen EL, Mjaaland I, Nielsen MEK, Poortmans P, Vikström J, Webb J, Offersen BV. Kaidar-Person O, et al. Among authors: yates es. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):20-29. doi: 10.1016/j.clon.2020.09.004. Epub 2020 Sep 26. Clin Oncol (R Coll Radiol). 2021. PMID: 32988717 Clinical Trial.
Proton therapy for early breast cancer patients in the DBCG proton trial: planning, adaptation, and clinical experience from the first 43 patients.
Fuglsang Jensen M, Stick LB, Høyer M, Kronborg CJS, Lorenzen EL, Mortensen HR, Nyström PW, Petersen SE, Randers P, Thai LMH, Yates ES, Offersen BV. Fuglsang Jensen M, et al. Among authors: yates es. Acta Oncol. 2022 Feb;61(2):223-230. doi: 10.1080/0284186X.2021.1986229. Epub 2021 Oct 10. Acta Oncol. 2022. PMID: 34632922 Clinical Trial.
Partial Breast Irradiation Versus Whole Breast Irradiation for Early Breast Cancer Patients in a Randomized Phase III Trial: The Danish Breast Cancer Group Partial Breast Irradiation Trial.
Offersen BV, Alsner J, Nielsen HM, Jakobsen EH, Nielsen MH, Stenbygaard L, Pedersen AN, Thomsen MS, Yates E, Berg M, Lorenzen EL, Jensen I, Josipovic M, Jensen MB, Overgaard J; Danish Breast Cancer Group Radiotherapy Committee. Offersen BV, et al. J Clin Oncol. 2022 Dec 20;40(36):4189-4197. doi: 10.1200/JCO.22.00451. Epub 2022 Aug 5. J Clin Oncol. 2022. PMID: 35930754 Clinical Trial.
20 results